Status:
TERMINATED
NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy
Lead Sponsor:
Brooks Rehabilitation
Conditions:
Blepharoptosis
Lagophthalmos
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Traumatic brain injury, stroke and other neurological conditions may result in weakness of the muscles that either open or close the eye. This is generally a result of impaired functioning of the ocul...
Eligibility Criteria
Inclusion
- Cranial nerve III (oculomotor nerve) and/or cranial nerve IV (facial nerve) palsy.
- Able to read and communicate in English.
Exclusion
- Idiopathic onset of CN III and/or CN IV palsy.
- Traumatic injury to the eye or eyelid.
- Active wounds in the treatment area.
- Presence of swelling or infection in or surrounding the affected eye.
- Diminished sensation in the area to be treated.
Key Trial Info
Start Date :
January 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 16 2019
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03239418
Start Date
January 6 2017
End Date
October 16 2019
Last Update
December 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooks Rehabilitation
Jacksonville, Florida, United States, 32216